Loading clinical trials...
Loading clinical trials...
This study investigates whether current cefazolin dosing guidelines for obese patients-2 g IV for those \<120 kg and 3 g IV for those ≥120 kg-achieve adequate plasma and tissue concentrations (≥8 mg/L...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Laval University
Collaborators
NCT07230769 · Bariatric Sleeve Gastrectomy
NCT06426836 · Pharmacokinetics, Amoxicillin-clavulanate, and more
NCT07319390 · Bariatric Sleeve Gastrectomy
NCT05132829 · Preterm Birth, Obstetric Labor, Premature, and more
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions